Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Free Report) was the recipient of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 2,000,000 shares, an increase of 8.1% from the June 15th total of 1,850,000 shares. Based on an average daily volume of 3,360,000 shares, […]
Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS – Get Rating) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 571,400 shares, a decline of 81.3% from the March 15th total of 3,060,000 shares. Based on an average trading volume of 1,580,000 shares, the days-to-cover ratio is […]